The focus of this learning activity is to offer an opportunity for current and prospective members of interprofessional healthcare bioethics committees to gain introductory knowledge of healthcare-related ethical issues.
Steven Ringer, MD, Ph.D., HEC-C
Section Chief of Neonatology^; Professor of Pediatrics*
Elizabeth Stanton, PA, J.D.
Director of Regional Risk Management, Risk Management^
^ Dartmouth Hitchcock Medical Center, Lebanon, NH
* Geisel School of Medicine, Hanover, NH
At the conclusion of this learning activity, (at least 75% of) participants will be able to identify key stakeholders in a health care ethics committee in order to ensure appropriate processes are addressed during discussion.
The activity director(s), planning committee member(s), speaker(s), author(s) or anyone in a position to control the content for this activity have reported NO financial relationship(s)* with ineligible companies**.
* A financial relationship" includes employee, researcher (named as the PI), consultant, advisor, speaker, independent contractor (including contracted research), royalties or patent beneficiary, executive role, and/or an ownership interest (not including stocks owned in a managed portfolio).
** An ineligible company is any entity whose primary business is producing, marketing, selling, re-selling, or distributing healthcare products used by or on patients.
- Carrese JA. HCEC pearls and pitfalls: suggested do's and don't's for healthcare ethics consultants. J Clin Ethics 2012; 23:234-40.
- Fletcher J, Siegler M. What are the goals of ethics consultation? A Consensus Statement. J Clinical Ethics 1996; 7:122-126.
- Fox E, Myers S, Pearlman R. Ethics Consultation in United States Hospitals: A National Survey. Am J Bioethics 2007; 7(2) 13-25.
- Fox E. The Road to Certification for Clinical Ethics Consultants: Finding Our Bearings. Am J Bioethics 2016; 16(3):33-37.
- Kelly DF, Hoyt JW. Ethics Consultation. Medical Ethics. 1996; 12(1) 49-70.